Pharmafile Logo
Pharmafocus logo
Advanced Search

Questcor buys API specialist BioVectra for $51m

January 8, 2013
Manufacturing and Production API, Achtar, BioVectra, Questcor

US biopharma firm Questcor has signed a deal to acquire Canadian active pharmaceutical ingredient (API) manufacturer BioVectra for an upfront …

News

Boehringer hands back Lilly drug

January 8, 2013
Research and Development, Sales and Marketing Boehringer, Tradjenta, diabetes, lilly

Boehringer Ingelheim has handed back one of Eli Lilly’s investigational diabetes drugs as a result of ‘independent strategic portfolio considerations’. …

News
Valeant image

Valeant shuts plant in Brazil, second to follow

January 8, 2013
Manufacturing and Production Brazil, Medicis, Valeant

Canadian firm Valeant Pharmaceuticals has closed down one of its facilities in Brazil and will shutter a second in the …

News
Eisai image

Eisai and Novartis part ways

January 8, 2013
Sales and Marketing COPD, Eisai, Novartis, Onbrez, Spiriva

Novartis and Eisai have abandoned their co-promotion agreement for three of Novartis’ chronic obstructive pulmonary disease treatments. The move follows …

News

Novo Nordisk appoints Curtis Oltmans to US executive team

January 8, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, Oltmans

Novo Nordisk has announced that Curtis Oltmans has been promoted to corporate vice president and general counsel, Legal and Quality …

Appointment

Marketing excellence: how to win over your internal audience

January 7, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MSI, Manastersky, marketing

You’ve spent months building a marketing excellence training curriculum which has been prioritised by marketing leadership as a critically important …

Feature
david_cook

David Cook appointed chief financial officer of Biotie

January 7, 2013
Manufacturing and Production, Research and Development, Sales and Marketing Biotie, David Cook

David Cook has been appointed chief financial officer (CFO) of drug development firm Biotie Therapies and will become a member …

Appointment

AbbVie splits from Abbott

January 7, 2013
Sales and Marketing AbbVie, Abbott, HIV, Humira

AbbVie, the new $18 billion biopharma company which includes many of Abbott’s most high profile products, has finally launched. Abbott …

News

Pressure on pharma M&A

January 7, 2013
Research and Development, Sales and Marketing Ernst & Young, M&A, MA, mergers

The world’s largest pharma companies will be under greater pressure to merge with or purchase other firms over the next …

News
lucentis

New price and data changes NICE view on Lucentis

January 4, 2013
Sales and Marketing Bayer, Eylea, Lucentis, NICE, Novartis

A new lower price and new data analysis has persuaded NICE to recommend Lucentis for patients with diabetic macular oedema …

News
sarah_bater

Celgene appoints new Human Resources director

January 2, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene

Celgene has announced the appointment of Sarah Bater as director of Human Resources, Celgene UK and Ireland. Bater brings a wealth …

Appointment

Contract research news in brief

December 21, 2012
Research and Development Almac, Clinipace, Harrison Clinical Research, PRA, Quintiles, Synteract, WuXi PharmaTech

Synteract agrees to by Harrison Clinical Research, WuXi forges JV with PR, plus appointments and a new accreditation for Quintiles’ …

News

Pharma manufacturing news in brief

December 21, 2012
Manufacturing and Production Amarin, BASF, Bioden Idec, Eisai, Lonza, Patheon, Sartorious Stedim Biotech, banner pharmacaps

BASF extends offer for ProNova, Patheon closes Banner Pharmacaps deal, plus updates from Amarin, Biogen Idec/Eisai and Lonza.

News

DH digital strategy released

December 21, 2012
Medical Communications DH, NHS, digital

The Department of Health has signalled its desire to make a splash in the digital pond with the release of …

News
4-gerresheimer-sign

Gerresheimer buys Indian pharma packaging specialist

December 21, 2012
Manufacturing and Production Gerresheimer, Triveni

Glass and plastic packaging specialist Gerresheimer has acquired a majority stake in Indian company Triveni Polymers Pvt in a bid …

News

Merck KGaA pipeline hit

December 21, 2012
Research and Development, Sales and Marketing Cancer, Merck KGaA, NSCLC, pipeline

Merck KGaA’s pipeline has been dented by the ‘disappointing’ late-stage failure of Stimuvax in a programme with non-small cell lung …

News

NHS blueprint under fire

December 20, 2012
Sales and Marketing CB, CCGs, Labour, NHS

The NHS Commissioning Board’s blueprint for care has promised extra funds for health providers and greater transparency for patients. Board …

News

Sanofi global operations president to retire

December 20, 2012
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hanspeter Spek, Sanofi

Sanofi has announced that Hanspeter Spek, president, Global Operations, will retire from his current role in mid-2013. Christopher Viehbacher, chief executive …

Appointment
NHS image

Mixed response to ‘seven-day’ NHS

December 20, 2012
Sales and Marketing BMA, CCGs, NHS, RCP

The NHS’s possible move to seven-day working has received a mixed welcome, with the BMA dubbing the proposals ‘too crude’. …

News
amgen image

$700m fines for Amgen

December 20, 2012
Manufacturing and Production, Sales and Marketing Amgen, FDA, off label, off-label

Amgen has pleaded guilty to misbranding its anaemia drug Aranesp following a string of US lawsuits against the biotech company. The …

News
The Gateway to Local Adoption Series

Latest content

Five Facts about the menopause

March 6, 2026

Zello Appoints Kevin Bailey as Group Chief Medical Officer

March 6, 2026

BioDuro establishes joint manufacturing venture with Cenra

March 6, 2026

Symbiosis appoints Joanne Anderson as Chief Commercial Officer

March 6, 2026

Secarna Pharmaceuticals and Curie.Bio expand existing partnership

March 6, 2026